SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-10-000117
Filing Date
2010-02-03
Accepted
2010-02-03 16:32:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO THE SCHEDULE 13G sc13ga407422cyp_12312009.htm SC 13G/A 228587
2 JOINT FILING AGREEMENT ex991to13ga407422cyp_123109.htm EX-99.1 31088
  Complete submission text file 0000921895-10-000117.txt   261733
Mailing Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121
Business Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121 8584522323
CYPRESS BIOSCIENCE INC (Subject) CIK: 0000716054 (see all company filings)

IRS No.: 222389839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35589 | Film No.: 10571085
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice